July 10, 2013

A new app for Android and the Apple iPhone aims to combine technology with psychology to reduce poor patient adherence to medication therapies.

July 10, 2013

Pharmacy ownership was once again a key aspect of McKesson ideaShare, as McKesson hosted its sixth annual RxOwnership program on June 29 to help advise independent pharmacy operators that are looking to buy or sell an existing store.

July 10, 2013

Many patients are not complying with their prescription drug therapies due to adverse side effects, even though some OTC drugs can treat them, according to a new study commissioned by a maker of products for dry mouth, one of the most common medication side effects.

July 9, 2013

Amgen will get rights to a drug for cardiovascular disease approved in the European Union under a new deal with French drug maker Servier, the two companies said.

July 9, 2013

A nonprofit pharmacy advocacy group has launched a new project that it said was aimed at ensuring fair audit standards for prescription drug claims paid under the Medicare Part D program and protecting pharmacies and patients from what it called unfair audit and conduct practices by pharmacy benefit managers.

July 9, 2013

The Food and Drug Administration has approved a generic drug for treating Alzheimer's disease, FDA records showed.

July 9, 2013

Mylan has received tentative approval for a generic version of a cholesterol drug made by AstraZeneca, according to Food and Drug Administration records.

July 9, 2013

The Food and Drug Administration has made a significant dent in its large backlog of generic drug applications thanks to amendments to last year's reauthorization of the Prescription Drug User Fee Act, the agency said.

July 9, 2013

The Food and Drug Administration has approved a new drug for treating opioid dependence.

July 9, 2013

The U.S. healthcare system has saved $25.5 billion over seven years from generic drugs launched under patent settlements between branded and generic drug manufacturers, according to a new study.

July 9, 2013

With some studies showing that patients' failure to take their medications as directed costs the economy nearly $300 billion per year, one group is looking to tackle what it sees as part of the problem: doctors' and pharmacists' instructions to patients on how much medicine to take and when.

July 9, 2013

Vitabath is expanding its fragrance collection with a new line of body lotions infused with vitamins and antioxidants.

July 8, 2013

Inquiries by pharmacists with doctors regarding the rationale behind prescriptions, diagnoses and treatment plans are inappropriate, according to a new resolution by the American Medical Association.

July 8, 2013

Nearly 30 children have been accidentally poisoned by opioid painkiller patches since 1997, according to the Food and Drug Administration, prompting the agency to issue disposal guidelines.

July 8, 2013

Amid mounting evidence of the negative clinical and economic consequences of medication nonadherence, research featured on the cover of this month’s Health Affairs breaks new ground by urging innovative approaches to improve medication adherence and to “achieve a higher-performing health system.”

July 3, 2013

Drug maker Impax Labs is hoping to become the first to market a generic version of a drug used to treat incontinence and overactive bladder, the company said Wednesday.

July 3, 2013

Oregon Gov. John Kitzhaber, a Democrat, has signed what the National Association of Community Pharmacy has characterized as groundbreaking reform legislation that applies reasonable standards to how pharmacy benefit managers audit community pharmacies, provides increased transparency into generic prescription drug reimbursement and ensures that PBM administrators of prescription drug claims are registered within the state.

July 3, 2013

Walgreens posted June sales of $5.8 billion, an increase of 2.5% from the same month in fiscal 2012, and saw increased pharmacy sales of 2.9%.

July 2, 2013

A dramatic increase in the number of women dying from opioid painkiller overdoses has health officials alarmed.

July 2, 2013

One of the most effective levers pharmacists and other health professionals can pull to curb the nation’s $2.7 trillion health care bill is boosting patients’ adherence to their prescription drug treatment regimens. But who’s holding the handle?

July 2, 2013

The Food and Drug Administration has approved a gel formulation of a foot fungus drug made by Merz Pharmaceuticals, according to published reports.

July 2, 2013

Sandoz, the generics division of Swiss drug maker Novartis, announced the launch of metronidazole 1% topical gel, calling it the first generic version of Galderma Labs' Metrogel.

July 2, 2013

Sandoz has started a late-stage clinical trial of a biosimilar version of a drug used to treat autoimmune disorders, hoping the results will support its efforts to win regulatory approval in the United States and Europe.

July 1, 2013

CVS Caremark has released the “2013 State of States: Adherence Report,” which reviews how patients in all 50 states are, or are not, taking their medications as directed by their doctors.

This is important as medication nonadherence continues to be a significant issue within the U.S. healthcare system. To be more specific, medication nonadherence in the U.S. accounts for up to $290 billion in excess healthcare costs annually. Yes, billion.